［1］ Khushman M,Patel GK,Laurini JA,et al.Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma［J］.J Gastrointest Oncol,2019,10(4):695-702.
［2］ Orth M,Metzger P,Gerum S,et al.Pancreatic ductal adenocarcinoma:Biological hallmarks,current status,and future perspectives of combined modality treatment approaches［J］.Radiat Oncol,2019,14(1):141.
［3］ Baliyan V,Kordbacheh H,Parakh A,et al.Response assessment in pancreatic ductal adenocarcinoma:Role of imaging［J］.Abdom Radiol (NY),2018,43(2):435-444.
［4］ Loizou L,Albiin N,Leidner B,et al.Multidetector CT of pancreatic ductal adenocarcinoma:Effect of tube voltage and iodine load on tumour conspicuity and image quality［J］.Eur Radiol,2016,26(11):4021-4029.
［5］ Bhosale P,Le O,Balachandran A,et al.Quantitative and qualitative comparison of single-source dual-energy computed tomography and 120-kVp computed tomography for the assessment of pancreatic ductal adenocarcinoma［J］.J Comput Assist Tomogr,2015,39(6):907-913.
［6］ Stiller W,Skornitzke S,Fritz F,et al.Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements:Are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional computed tomography perfusion［J］?Invest Radiol,2015,50(10):703-708.
［7］ ZHAO CH,HAO FE,LIU AS.Correlation between quantitative dual-energy CT iodine maps and CT perfusion parameters in patients with pancreatic carcinoma［J］.Radiol Practice,2018,33(6):587-592.［赵常红，郝粉娥，刘挨师.胰腺癌定量双能CT碘图与CT灌注参数相关性研究［J］.放射学实践,2018,33(6):587-592.］
［8］ Park HJ,Jang KM,Song KD,et al.Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma［J］.Clin Radiol,2017,72(12):1076-1084.
［9］ Lee S,Kim JH,Kim SY,et al.Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma［J］.Eur Radiol,2018,28(12):5267-5274.
［10］ Ma C,Li Y,Wang L,et al.Intravoxel incoherent motion DWI of the pancreatic adenocarcinomas:Monoexponential and biexponential apparent diffusion parameters and histopathological correlations［J］.Cancer Imaging,2017,17(1):12.
［11］ Kartalis N,Manikis GC,Loizou L,et al.Diffusion-weighted MR imaging of pancreatic cancer:A comparison of mono-exponential,bi-exponential and non-gaussian kurtosis models［J］.Eur J Radiol Open,2016(3):79-85.
［12］ Wegner CS,Gaustad JV,Andersen LM,et al.Diffusion-weighted and dynamic contrast-enhanced MRI of pancreatic adenocarcinoma xenografts:Associations with tumor differentiation and collagen content［J］.J Transl Med,2016,14(1):161.
［13］ Wegner CS,Hauge A,Simonsen TG,et al.DCE-MRI of sunitinib-induced changes in tumor microvasculature and hypoxia:A study of pancreatic ductal adenocarcinoma xenografts［J］.Neoplasia,2018,20(7):734-744.
［14］ Liu Y,Wang M,Ji R,et al.Differentiation of pancreatic ductal adenocarcinoma from inflammatory mass:Added value of magnetic resonance elastography［J］.Clin Radiol,2018,73(10):865-872.
［15］ LIU Y,ZHANG J,ZUO CJ.Imaging differential diagnosis of chronic mass pancreatitis and pancreatic cancer［J］.Chin J Pancreatol,2015,15(1):59-63.［刘瑶,张建,左长京.慢性肿块型胰腺炎与胰腺癌的影像学鉴别诊断［J］.中华胰腺病杂志,2015,15(1):59-63.］
［16］ Aslan S,Nural MS,Camlidag I,et al.Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions［J］.Abdom Radiol (NY),2019,44(2):593-603.
［17］ Yin Q,Zou X,Zai X,et al.Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis:Differentiation with dual-energy MDCT in spectral imaging mode［J］.Eur J Radiol,2015,84(12):2470-2476.
［18］ Jae Hyun K,Jeong Min L,Hoon PJ,et al.Solid pancreatic lesions:Characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment-a preliminary study［J］.Radiology,2013,266(1):185-196.
［19］ Huang WC,Sheng J,Chen SY,et al.Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis:Usefulness of high B value diffusion-weighted imaging［J］.J Dig Dis,2011,12(5):401-408.
［20］ Klauss M,Lemke A,Grunberg K,et al.Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma［J］.Invest Radiol,2011,46(1):57-63.
［21］ Shi Y,Gao F,Li Y,et al.Differentiation of benign and malignant solid pancreatic masses using magnetic resonance elastography with spin-echo echo planar imaging and three-dimensional inversion reconstruction:A prospective study［J］.Eur Radiol,2017,28(3):1-10.
［22］ Jornet D,Soyer P,Terris B,et al.MR imaging features of pancreatic acinar cell carcinoma［J］.Diagn Interv Imaging,2019,100(7-8):427-435.
［23］ Sumiyoshi T,Shima Y,Okabayashi T,et al.Comparison of pancreatic acinar cell carcinoma and adenocarcinoma using multidetector-row computed tomography［J］.World J Gastroenterol,2013,19(34):5713-5719.
［24］ JIA HH,LIN GW,LI SH,et al.The value of time attenuation curve in differential diagnosis between acinar cell carcinoma and ductal adenocarcinoma of pancreas［J］.J Pract Radiol,2018,8(34):1206-1209.［贾惠惠，林光武，李仕红，等.时间衰减曲线用于区分胰腺腺泡细胞癌和胰腺导管腺癌的价值［J］.实用放射学杂志,2018,8(34):1206-1209.］
［25］ Wang Q,Wang X,Guo R,et al.A comparison study of pancreatic acinar cell carcinoma with ductal adenocarcinoma using computed tomography in Chinese patients［J］.Oncotargets & Therapy,2016(9):5475-5481.
［26］ Guo C,Zhuge X,Wang Q,et al.The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma:The values of CT imaging features and texture analysis［J］.Cancer Imaging,2018,18(1):37.
［27］ Lee S,Kim SH,Park HK,et al.Pancreatic ductal adenocarcinoma:Rim enhancement at MR imaging predicts prognosis after curative resection［J］.Radiology,2018,288(2):456-466.
［28］ Chang ST,Jeffrey RB,Patel BN,et al.Preoperative multidetector CT diagnosis of extrapancreatic perineural or duodenal invasion is associated with reduced postoperative survival after pancreaticoduodenectomy for pancreatic adenocarcinoma:Preliminary experience and implications for patient care［J］.Radiology,2016,281(3):816-825.
［29］ Chakraborty J,Langdon-Embry L,Cunanan KM,et al.Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients［J］.PloS One,2017,12(12):e0188022.
［30］ Attiyeh MA,Chakraborty J,Doussot A,et al.Survival prediction in pancreatic ductal adenocarcinoma by quantitative computed tomography image analysis［J］.Ann Surg Oncol,2018,25(4):1034-1042.
［31］ Eilaghi A,Baig S,Zhang Y,et al.CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma-a quantitative analysis［J］.BMC Med Imaging,2017,17(1):38.
［32］ Choi MH,Lee YJ,Yoon SB,et al.MRI of pancreatic ductal adenocarcinoma:Texture analysis of T2-weighted images for predicting long-term outcome［J］.Abdom Radiol (NY),2019,44(1):122-130.